251 related articles for article (PubMed ID: 27379987)
1. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Glioma Detection Using an EGFR-Targeted Fluorescent Affibody.
Ribeiro de Souza AL; Marra K; Gunn J; Samkoe KS; Hull S; Paulsen KD; Pogue BW
Photochem Photobiol; 2018 Nov; 94(6):1167-1171. PubMed ID: 30129069
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
[TBL] [Abstract][Full Text] [Related]
4. Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes.
Holt RW; Demers JL; Sexton KJ; Gunn JR; Davis SC; Samkoe KS; Pogue BW
J Biomed Opt; 2015 Feb; 20(2):26001. PubMed ID: 25652703
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.
Sexton K; Tichauer K; Samkoe KS; Gunn J; Hoopes PJ; Pogue BW
PLoS One; 2013; 8(4):e60390. PubMed ID: 23593208
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
7. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
8. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
[TBL] [Abstract][Full Text] [Related]
9. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
[TBL] [Abstract][Full Text] [Related]
10. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
[TBL] [Abstract][Full Text] [Related]
11. Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas.
Gibbs-Strauss SL; Samkoe KS; O'Hara JA; Davis SC; Hoopes PJ; Hasan T; Pogue BW
Acad Radiol; 2010 Jan; 17(1):7-17. PubMed ID: 19796971
[TBL] [Abstract][Full Text] [Related]
12. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
[TBL] [Abstract][Full Text] [Related]
13. Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
Shazeeb MS; Sotak CH; DeLeo M; Bogdanov A
Cancer Res; 2011 Mar; 71(6):2230-9. PubMed ID: 21245103
[TBL] [Abstract][Full Text] [Related]
14. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
Tolmachev V; Rosik D; Wållberg H; Sjöberg A; Sandström M; Hansson M; Wennborg A; Orlova A
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):613-22. PubMed ID: 19838701
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous
Elliott JT; Marra K; Evans LT; Davis SC; Samkoe KS; Feldwisch J; Paulsen KD; Roberts DW; Pogue BW
Clin Cancer Res; 2017 May; 23(9):2203-2212. PubMed ID: 27799250
[No Abstract] [Full Text] [Related]
17. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
Kim H; Cho MH; Choi HS; Lee BI; Choi Y
Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
[TBL] [Abstract][Full Text] [Related]
18. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
19. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
[No Abstract] [Full Text] [Related]
20. Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas.
Streeter SS; Xu X; Hebert KA; Werth PM; Hoopes PJ; Jarvis LA; Pogue BW; Paulsen KD; Samkoe KS; Henderson ER
Mol Imaging Biol; 2024 Apr; 26(2):272-283. PubMed ID: 38151580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
